| Literature DB >> 22533459 |
Arinze S Okoli1, Mark J Raftery, George L Mendz.
Abstract
BACKGROUND: Helicobacter hepaticus colonizes the intestine and liver of mice causing hepatobiliary disorders such as hepatitis and hepatocellular carcinoma, and has also been associated with inflammatory bowel disease in children. In its habitat, H. hepaticus must encounter bile which has potent antibacterial properties. To elucidate virulence and host-specific adaptation mechanisms of H. hepaticus modulated by human or porcine bile, a proteomic study of its response to the two types of bile was performed employing two-dimensional gel electrophoresis (2-DE) and mass spectrometry.Entities:
Year: 2012 PMID: 22533459 PMCID: PMC3352258 DOI: 10.1186/1477-5956-10-27
Source DB: PubMed Journal: Proteome Sci ISSN: 1477-5956 Impact factor: 2.480
Figure 1Change in morphology of . In both types of bile, the percentage of coccoid forms in the bacterial population was higher at high bile concentrations. Data and standard errors are from three independent experiments.
Figure 2Growth of . The controls were cultures without bile [c]. Growth rate of H. hepaticus between 0 and 60 h in 0% bile (♦), 0.05% human bile (■), 0.1% human bile (▲), 0.1% porcine bile (×), and 0.25% porcine bile (●). The data and standard errors are from three independent experiments.
Figure 32D-gels showing . Proteins were extracted from bacterial cells grown at 0% Human bile [a], 0.05% Human bile [b]; 0% Porcine bile [c], and 0.1% Porcine bile [d]. Differentially expressed protein spots are numbered on the gels, orange characters indicate up-regulated spots while dark characters indicate down-regulated spots. Proteins in spots were identified by LC-MS/MS and listed in Table 1.
Proteins of H.hepaticus identified by LC-MS/MS whose expression was modulated by at least 2-fold in 0.05% human- or 0.1% porcine bile in the growth media
| Gene | Coverage (Peptide) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Human | Porcine | Human | Porcine | Human | Porcine | Human | Porcine | Human | Porcine | |||
| Dihydropicolinate reductase* | 0.4 ± 0.01 | 3.5 ± 0.03 | Lysine biosynthesis | 33 | 23 | 438 | 201 | 33(7) | 26(12) | 6.59/6.24 | 5.7/6.24 | |
| Dihydropicolinate reductase* | 0.1 ± 0.01 | NI | 32 | - | 430 | - | 44(19) | - | 6.50/6.24 | - | ||
| Glycine hydroxymethyltransferase | 0.48 ± 0.1 | 2.5 ± 0.01 | Glycine hydroxymethyltransferase | 18 | 17 | 330 | 278 | 26(6) | 16(5) | 6.57/6.33 | 6.95/6.33 | |
| Ketol-acid reductoisomerase | 2.7 ± 0.3 | NI | Valine, leucine and isoleucine biosynthesis | 27 | - | 916 | 49(14) | - | 6.59/6.05 | - | ||
| Threonyl-tRNA synthetase | NI | 4.0 ± 0.01 | Glycine, threonine and serine metabolism | - | 8 | - | 214 | - | 12(3) | - | 5.78/6.06 | |
| 2-isopropylmalate synthase | NI | 5.0 ± 0.01 | Valine, leucine and isoleucine biosynthesis | - | 9 | - | 148 | - | 26(12) | - | 5.78/5.86 | |
| Phosphoglycerate dehydrogenase | NI | 0.4 ± 0.02 | Serine family amino acid biosynthesis | - | 32 | - | 583 | - | 18(9) | - | 5.70/5.84 | |
| ATP-dependent CLP protease* | NI | 0.3 ± 0.01 | Endopeptidase activity | - | 3 | - | 941 | - | 41(19) | - | 5.92/5.70 | |
| ATP-dependent CLP protease* | NI | 0.2 ± 0.06 | - | 4 | - | 1167 | - | 38(36) | - | 5.84/5.70 | ||
| Aconitase* | 0.25 ± 0.01 | 0.4 ± 0.01 | Citrate cycle, glyoxylate and dicarboxylate metabolism, reductive carboxylate cycle | 2 | 2 | 1237 | 784 | 48(28) | 10(13) | 6.65/6.21 | 6.46/6.21 | |
| Aconitase* | 0.1 ± 0.03 | 0.4 ± 0.01 | 3 | 1 | 1491 | 665 | 29(20) | 29(11) | 6.54/6.21 | 6.54/6.21 | ||
| Aconitase* | 0.1 ± 0.01 | NI | 1 | - | 1488 | - | 43(14) | - | 6.76/6.21 | - | ||
| Aconitase* | 0.2 ± 0.01 | NI | 4 | - | 866 | - | 34(12) | - | 6.46/6.21 | - | ||
| Alkyl hydroperoxide reductase | NI | 3.0 ± 0.01 | Oxidative phosphorylation | - | 28 | - | 288 | - | 50(17) | - | 6.3/5.95 | |
| ATP synthase subunit A | NI | 4.0 ± 0.02 | - | 12 | - | 891 | - | 43(19) | - | 5.7/5.69 | ||
| ATP synthase subunit B | NI | 2.5 ± 0.1 | - | 15 | - | 1509 | - | 53(12) | - | 5.12/5.17 | ||
| dDTP-glucose dehydratase | 0.3 ± 0.01 | NI | Nucleotide sugar biosynthesis | 23 | - | 549 | - | 31(5) | - | 5.57/6.05 | - | |
| UDP-glucose 6-dehydrogenase | 0.24 ± 0.06 | NI | Pentose and glucuronate interconversions; starch & sucrose metabolism, nucleotide sugars metabolism | 17 | - | 384 | - | 50(17) | - | 5.51/5.27 | - | |
| Ferredoxin oxidoreductase* | 3.5 ± 0.02 | NI | Pyruvate metabolism | 37 | - | 514 | - | 11(4) | - | 5.92/5.91 | - | |
| Ferredoxin oxidoreductase* | 2.5 ± 0.3 | NI | 22 | - | 900 | - | 35(20) | - | 6.38/5.91 | - | ||
| Fumarase | 0.25 ± 0.1 | 0.4 ± 0.1 | Citrate cycle, reductive carboxylate cycle | 30 | 13 | 566 | 725 | 47(8) | 23(11) | 6.62/5.61 | 5.7/5.61 | |
| Fumarate reductase | NI | 6.0 ± 0.1 | Citrate cycle, oxidative phosphorylation | - | 6 | - | 734 | - | 38(36) | - | 5.7/7.23 | |
| Fructose-bisphosphate aldolase | 2.8 ± 0.01 | NI | Glycolysis, gluconogenesis | 19 | - | 975 | - | 50(13) | - | 6.59/5.95 | - | |
| Isocitrate dehydrogenase | NI | 5.5 ± 0.02 | Citrate cycle | - | 5 | - | 865 | - | 23(7) | - | 5.7/7.10 | |
| Malate dehydrogenase | NI | 2.0 ± 0.01 | Pyruvate metabolism | - | 21 | - | 710 | - | 42(9) | - | 6.89/8.11 | |
| Phosphoglycerate kinase | 2.5 ± 0.01 | NI | Glycolysis, glyconogenesis | 13 | - | 699 | - | 44(10) | - | 6.0/5.64 | - | |
| Rod shape determining protein | 2.5 ± 0.2 | NI | Cell shape determining protein | 20 | - | 455 | - | 33(7) | - | 5.27/5.16 | - | |
| Catalase | NI | 0.1 ± 0.01 | Superoxide metabolism | - | 10 | - | 715 | - | 27(5) | - | 5.7/6.75 | |
| Superoxide dismutase | 0.1 ± 0.01 | 0.4 ± 0.3 | 16 | 27 | 137 | 411 | 13(2) | 31(9) | 6.49/6.24 | 5.7/6.24 | ||
| Thioredoxin reductase | 0.3 ± 0.01 | 4.7 ± 0.03 | Oxygen & ROS metabolism | 31 | 18 | 470 | 390 | 27 (12) | 14(5) | 5.41/5.34 | 5.30/5.34 | |
| Putative thioredoxin reductase (HH1153) | 0.2 ± 0.01 | NI | 24 | - | 381 | - | 16(5) | - | 5.95/6.15 | - | ||
| Hsp-70 (DnaK cofactor) | 2.3 ± 0.03 | NI | Heat shock protein | 26 | - | 308 | - | 11(8) | - | 4.57/4.62 | - | |
| Cpn60 | NI | 3.0 ± 0.01 | Chaperonin | - | 14 | - | 705 | - | 42(11) | - | 5.32/5.19 | |
| Acetyl-CoA caroxylase alpha subunit | 0.2 ± 0.01 | NI | Fatty acid biosynthesis | 41 | - | 277 | - | 32(4) | - | 5.59/5.47 | - | |
| 7-Alpha-dehydroxysteroid dehydrogenase | 2.5 ± 0.01 | NI | 46 | - | 629 | - | 23(11) | - | 6.19/7.59 | - | ||
| (3R)-hydroxymyristoyl ACP dehydratase | NI | 4.0 ± 0.01 | - | 7 | - | 356 | - | 28(6) | - | 6.95/6.31 | ||
| s-malonyltransferase | 0.3 ± 0.01 | NI | 15 | - | 311 | - | 31(5) | - | 5.49/5.45 | - | ||
| Flagellin* | 2.5 ± 0.3 | 2.0 ± 0.01 | Flagella assembly | 11 | 11 | 946 | 961 | 41(16) | 60(11) | 4.81/6.38 | 4.57/6.38 | |
| Flagellin* | 0.3 ± 0.02 | NI | 10 | - | 833 | - | 13(10) | - | 4.95/6.38 | - | ||
| Flagellin* | 0.4 ± 0.01 | NI | 9 | - | 699 | - | 26(9) | - | 4.89/6.38 | - | ||
| Flagellin assembly protein* | 0.4 ± 0.01 | NI | 35 | - | 474 | - | 31(5) | - | 4.86/4.93 | - | ||
| Flagellin assembly protein* | 0.3 ± 0.01 | NI | 34 | - | 466 | - | 57(8) | - | 4.80/4.93 | - | ||
| Major flagellin subunit | 2.4 ± 0.1 | NI | 12 | - | 827 | - | 47(13) | - | 4.68/5.56 | - | ||
| Two-component system response regulator | 0.4 ± 0.01 | NI | Two-component signal regulatory system | 36 | - | 154 | - | 16(9) | - | 4.84/5.63 | - | |
| Adenylate kinase | 0.2 ± 0.3 | NI | Purine metabolism | 40 | - | 833 | - | 35(20) | - | 5.22/5.09 | - | |
| DNA polymerase III subunit beta | 3.0 ± 0.01 | NI | DNA metabolism | 45 | - | 385 | - | 24(4) | - | 5.62/5.33 | - | |
| Cytolethal distending toxin | 0.1 ± 0.01 | NI | Virulence | 44 | - | 444 | - | 20(9) | - | 4.81/5.23 | - | |
| Urease subunit A | NI | 0.3 ± 0.03 | Urease activity, virulence | - | 24 | - | 393 | - | 52(8) | - | 5.32/5.93 | |
| Translation elongation factor Ts | 3.2 ± 0.01 | 2.0 ± 0.1 | Protein translation | 14 | 30 | 53 | 717 | 16(17) | 36(12) | 6.0/5.31 | 5.3/5.31 | |
| Translation elongation factor Tu | 2.5 ± 0.01 | 2.0 ± 0.1 | 43 | 26 | 64 | 173 | 11(6) | 15(13) | 6.81/4.93 | 5.49/5.12 | ||
| GTP-binding protein* | 3.5 ± 0.01 | NI | Signal transduction | 5 | - | 948 | - | 50(12) | - | 5.38/5.26 | - | |
| GTP-binding protein* | 3.0 ± 0.02 | NI | 6 | - | 706 | - | 42(11) | - | 5.43/5.26 | - | ||
| GTP-binding protein* | 2.7 ± 0.01 | NI | 7 | - | 954 | - | 31(11) | - | 5.49/5.26 | - | ||
| GTP-binding protein* | 3.5 ± 0.01 | NI | 8 | - | 638 | - | 37(9) | - | 5.54/5.26 | - | ||
| Putative ATP/GTP-binding protein | 3.5 ± 0.02 | NI | 38 | - | 700 | - | 26(17) | - | 6.08/5.77 | - | ||
| Amino-acid ABC transporter periplasmic solute-binding protein | 0.3 ± 0.1 | NI | ABC transporter protein | 39 | - | 396 | - | 24(4) | - | 4.97/5.17 | - | |
| Putative ABC transporter protein | 0.4 ± 0.01 | NI | 29 | - | 494 | - | 57(5) | - | 4.81/5.16 | - | ||
| Single-stranded DNA-binding protein | NI | 0.3 ± 0.1 | Single strand binding protein/primosomal replication | - | 25 | - | 238 | - | 27(4) | - | 5.38/5.91 | |
| HH1212 | 0.1 ± 0.03 | NI | Hypothetical protein | 25 | - | 349 | - | 14(5) | - | 6.34/6.98 | - | |
| HH0952 | 0.3 ± 0.02 | NI | 28 | - | 267 | - | 9(3) | - | 4.27/4.52 | - | ||
| HH1514 | 0.4 ± 0.01 | NI | 42 | - | 286 | - | 17(9) | - | 5.97/5.62 | - | ||
| HH1023 | 0.2 ± 0.01 | 0.2 ± 0.01 | 21 | 16 | 1312 | 410 | 43(21) | 31(6) | 5.86/6.15 | 5.86/6.15 | ||
| HH1098 | NI | 4.0 ± 0.01 | - | 31 | - | 156 | - | 10(2) | - | 5.7/5.71 | ||
| HH1376 | NI | 0.3 ± 0.01 | - | 19 | - | 121 | - | 11(3) | - | 5.89/5.62 | ||
| HH1034 | NI | 2.5 ± 0.1 | - | 20 | - | 410 | - | 53(9) | - | 6.73/6.22 | ||
| HH1426 | NI | 0.4 ± 0.1 | - | 22 | - | 348 | - | 28(6) | - | 6.49/6.12 | ||
| HH0243 | NI | 2.5 ± 0.01 | - | 29 | - | 297 | - | 22(4) | - | 5.59/5.63 | ||
aProteins were identified by LC-MS/MS and MASCOT searches of the NCBI nr database. bProteins that were differentially expressed in the presence of 0.05% human bile or 0.1% porcine bile by at least 2-fold level of expression. A fold change value of > 2 indicates up-regulation, while a value of < 0.5 indicates down-regulation. cProteins were classified into functional categories based on KEGG pathway classification and DAVID gene ontology, and by comparison with the published literature. dProteins with peptides with matching scores of > 49 were considered to be identified. ePredicted isoelectric point of each protein was obtained from the Comprehensive Microbial Resource of the Institute of Genomic Research. NI = Not identified.
Figure 4Differential expression of . 16 S rDNA was used as internal control to normalize the relative expressions of the genes. H. hepaticus specific primer set used for the qRT-PCR has been published previously [17] Experiments were performed in triplicate. Data and standard errors are from two independent experiments.